Outcomes in pandemic asthma diagnostics with home spirometry

P77 Table 1 n = 50 (%) Age (years) 44 Sex Male 9 18 Female 41 82 BMI (kg/m2) 30.7 On high dose inhaled corticosteroids (ICS) 49 98 No. of patients on at least 5mg daily prednisolone 19 38 No. of patients who had 2 or more courses of prednisolone 29 58 Ethnicity Caucasian 39 78 Black 1 2 Other 10 20 ConclusionsDomiciliary spirometry in a cohort of patients with a presumed diagnosis of difficult-to-treat asthma, enabled just over one in every ten patients to commence asthma biologic therapies, whilst allowing patients to limit extensive travel and remain out of the hospital environment. Further work is warranted to ensure feasibility, cost-effectiveness and patient compliance.